Cipla Q3 PAT may dip 6.4% YoY to Rs 700.3 cr: Prabhudas Lilladher

Prabhudas Lilladher has come out with its third quarter (October-December’ 21) earnings estimates for the Pharma sector. The brokerage house expects Cipla to report net profit at Rs 700.3 crore down 6.4% year-on-year (down 1.6% quarter-on-quarter).

Net Sales are expected to increase by 7.6 percent Y-o-Y (up 0.7 percent Q-o-Q) to Rs 5,560.6 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 2.4 percent Y-o-Y (down 2.1 percent Q-o-Q) to Rs 1,200.8 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.